Abstract:While near infrared fluorescence (NIRF) imaging has been widely used in preclinical studies, its low tissue penetration represents a daunting problem for translational clinical imaging of neurodegenerative diseases. Retina is known as an extension of the central nerve system (CNS), and it is widely considered as a window to a brain. Therefore, retina can be considered as an alternative organ for investigating neurodegenerative diseases. From an NIRF imaging standpoint, an eye represents an ideal imaging organ, due to its minimal opacity. In this report, we demonstrated that, for the first time, Near Infrared Fluorescence Ocular Imaging (NIRFOI) could potentially be applied for diagnosis of Alzheimer's disease. In our previous studies, we described “smart” fluorescent probes for amyloid beta (Ab) (CRANAD-X (X = -2, -3, -30, -58, and -102)) and used them for non-invasive NIRF imaging of Aβ species in brains of transgenic AD mice. Here, we demonstrated that these probes also could be used for imaging of Aβs in the eyes (Fig.1). Compared to NIRF of brains, NIRFOI has remarkable translational potential for future human studies, as the eye has significantly better transparency for optical imaging. Moreover, our preliminary results demonstrated that NIRFOI could provide much higher sensitivity for imaging Abs than brain NIRF did (Fig.1). This large margin is very important for both diagnosis and therapy response monitoring. Although fluorescence microscopic imaging has been used for detection of Ab plaques in AD mice and human AD patients, but it could not be used to detect soluble Aβs, because there is no observable morphology of soluble Aβs under fluorescence microscope. However, NIRFOI captures signals with a wide angle (large FOV), and can collect all of the signals from eyes. Therefore we believe that NIRFOI imaging is one of such technologies that can capture the imaging signals from both soluble and insoluble Aβ species.

Label-free autofluorescence and hyperspectral imaging of cerebral amyloid-β lesions in aged squirrel monkeys

Label-free imaging of amyloid plaques in Alzheimer's disease with stimulated Raman scattering microscopy.

Brain Clearance of Alzheimer's Amyloid-β40 in the Squirrel Monkey: A SPECT Study in a Primate Model of Cerebral Amyloid Angiopathy

Multiscale optical and optoacoustic imaging of amyloid-β deposits in mice

Noninvasive Visualization of Amyloid-Beta Deposits in Alzheimer's Amyloidosis Mice via Fluorescence Molecular Tomography Using Contrast Agent

Label-free hyperspectral imaging and deep-learning prediction of retinal amyloid β-protein and phosphorylated tau

A Novel Viscosity Sensitive Hemicyanine Fluorescent Dye for Real-Time Imaging of Amyloid-Β Aggregation

Spatial Frequency Domain Imaging of Intrinsic Optical Property Contrast in a Mouse Model of Alzheimer’s Disease

Visualizing Aβ Deposits in Live Young AD Model Mice with a Simple Red/near-Infrared-fluorescent AIEgen

Bioluminescence Imaging with Functional Amyloid Reservoirs in Alzheimer's Disease Models

Multimodal microscopy for characterization of amyloid-${\unicode[Times]{x3B2}}$ plaques biomarkers in animal model of Alzheimer's disease

In vivo evaluation of novel near-infrared fluorescence probe THK565 for imaging amyloid β and tau protein deposits in Alzheimer‘s mouse models

NEAR INFRARED FLUORESCENCE OCULAR IMAGING (NIRFOI) OF AMYLOID BETA SPECIES IN ALZHEIMER’S DISEASE

Long-Term Repeatable In Vivo Monitoring of Amyloid-β Plaques and Vessels in Alzheimer's Disease Mouse Model with Combined TPEF/CARS Microscopy

A Near-infrared Fluorescence and Positron Emission Tomography Bimodal Probe for in Vivo Imaging of Amyloid-β Species.

Retinal analysis of a mouse model of Alzheimer's disease with multi-contrast optical coherence tomography

In Vivo [18F]SMBT‐1 Imaging of Reactive Astrocytes in Mouse Models of Alzheimer’s Disease ‐ Temporospatial Relationship with Amyloid, Tau and Microgliosis

Turn-on chemiluminescence probes and dual-amplification of signal for detection of amyloid beta species in vivo

Comparing amyloid-β deposition, neuroinflammation, glucose metabolism, and mitochondrial complex I activity in brain: a PET study in aged monkeys

Quantitative chemical imaging of amyloid-β plaques with Raman micro-spectroscopy in human Alzheimer's diseased brains

Hyperspectral Retinal Imaging as a Non-Invasive Marker to Determine Brain Amyloid Status